Jianjun Han

Handan, 056002, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

AI in predicting the macrotrabecular-massive subtype of HCC and informing treatment selection: a multi-center and prospective validation study.

AI in predicting the macrotrabecular-massive subtype of HCC and informing treatment selection: a multi-center and prospective validation study.

Journal: NPJ precision oncology
Published: January 20, 2026

The impact of anti-M antibodies on patient blood typing and transfusion safety: a retrospective study.

The impact of anti-M antibodies on patient blood typing and transfusion safety: a retrospective study.

Journal: Laboratory medicine
Published: June 13, 2025

Circular RNA DENND4C Regulates Cell Malignant Behaviors in Breast Cancer Through the miR-26a-5p/HSPA8 Axis.

Circular RNA DENND4C Regulates Cell Malignant Behaviors in Breast Cancer Through the miR-26a-5p/HSPA8 Axis.

Journal: Breast cancer (Dove Medical Press)
Published: May 21, 2025

UGP2 is a potential target for breast cancer, based on bioinformatics analysis and in vitro experiments.

UGP2 is a potential target for breast cancer, based on bioinformatics analysis and in vitro experiments.

Journal: Scientific reports
Published: May 01, 2025

Clinical efficacy and therapy response prediction of neoadjuvant dalpiciclib plus letrozole in postmenopausal patients with HR+/HER2- stage II-III breast cancer (DARLING 01): a single-arm, open-label, exploratory study.

Clinical efficacy and therapy response prediction of neoadjuvant dalpiciclib plus letrozole in postmenopausal patients with HR+/HER2- stage II-III breast cancer (DARLING 01): a single-arm, open-label, exploratory study.

Journal: Breast cancer research : BCR
Published: December 04, 2024

Evidence-based general practice: a scoping review.

Evidence-based general practice: a scoping review.

Journal: BMC primary care
Published: November 19, 2024

Correction: Identification of serum prognostic marker miRNAs and construction of microRNA-mRNA networks of esophageal cancer.

Correction: Identification of serum prognostic marker miRNAs and construction of microRNA-mRNA networks of esophageal cancer.

Journal: PloS one
Published: April 19, 2024

An efficient DNAzyme-locked leakless enzyme-free amplification system for alpha-foetoprotein detection in liver cancer and breast cancer.

An efficient DNAzyme-locked leakless enzyme-free amplification system for alpha-foetoprotein detection in liver cancer and breast cancer.

Journal: Mikrochimica acta
Published: March 08, 2024

CircVIRMA enhances cell malignant behavior by governing the miR-452-5p/CREBRF pathway in cervical cancer.

CircVIRMA enhances cell malignant behavior by governing the miR-452-5p/CREBRF pathway in cervical cancer.

Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: February 23, 2024

RAB10 promotes breast cancer proliferation migration and invasion predicting a poor prognosis for breast cancer.

RAB10 promotes breast cancer proliferation migration and invasion predicting a poor prognosis for breast cancer.

Journal: Scientific reports
Published: April 18, 2023

A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of olanzapine plus triple antiemetic regimen for the prevention of multiday highly emetogenic chemotherapy-induced nausea and vomiting (OFFER study).

A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of olanzapine plus triple antiemetic regimen for the prevention of multiday highly emetogenic chemotherapy-induced nausea and vomiting (OFFER study).

Journal: EClinicalMedicine
Published: September 11, 2022

Circ_0001982 aggravates breast cancer development through the circ_0001982-miR-144-3p-GSE1 axis.

Circ_0001982 aggravates breast cancer development through the circ_0001982-miR-144-3p-GSE1 axis.

Journal: Journal of biochemical and molecular toxicology
Published: July 07, 2022
Showing 1-12 of 25

Last Updated: 09/26/2026